glp-1 news nov 2025 Coverage for some popular medications is set to go away in January What's next for GLP-1 innovation:

Eli Lilly is also developing oral GLP-1 receptor agonists, including compounds such as orforglipron, which have shown significant weight loss and glycemic improvements in Phase III clinical trials

Novo Nordisk and Eli Lilly, whose GLP-1 diabetes drug Mounjaro is expected to be approved for weight loss this year, are facing several lawsuits in the U.S

You can rotate injections between your stomach, upper arm, and thigh

Free Retatrutide Reconstitution Calculator The table above covers the most common setups, but if your vial size or desired dose doesn't fit neatly into those rows, our calculator handles any combination instantly

Diabetes Care 38 , 132139 (2015)

Type 2 Diabetes A diagnosis with ICD-10-CM codes E11*